We are live on ! Find out more
UTHR icon

United Therapeutics

461 hedge funds and large institutions have $9.45B invested in United Therapeutics in 2022 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 170 increasing their positions, 160 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more call options, than puts

Call options by funds: $104M | Put options by funds: $51M

2.74% more ownership

Funds ownership: 97.2%99.94% (+2.7%)

6% more repeat investments, than reductions

Existing positions increased: 170 | Existing positions reduced: 160

2% less funds holding

Funds holding: 472461 (-11)

9% less capital invested

Capital invested by funds: $10.3B → $9.45B (-$878M)

11% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 61

25% less funds holding in top 10

Funds holding in top 10: 2418 (-6)

Holders
461
Holders Change
-11
Holders Change %
-2.33%
% of All Funds
7.94%
Holding in Top 10
18
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-25%
% of All Funds
0.31%
New
54
Increased
170
Reduced
160
Closed
61
Calls
$104M
Puts
$51M
Net Calls
+$53.1M
Net Calls Change
+$3.64M
Name Holding Trade Value Shares
Change
Change in
Stake
AIMCA
126
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$7.08M
Canada Life
127
Canada Life
Manitoba, Canada
$7.07M +$308K +1,377 +4%
Susquehanna International Group
128
Susquehanna International Group
Pennsylvania
$7.04M +$7.13M +31,889 +1,866%
GC
129
Globeflex Capital
California
$6.98M +$5.9M +26,387 +381%
AB
130
Amalgamated Bank
New York
$6.92M +$71.3K +319 +1%
TPSF
131
Texas Permanent School Fund
Texas
$6.85M -$1.12K -5 -0%
Treasurer of the State of North Carolina
132
Treasurer of the State of North Carolina
North Carolina
$6.83M +$139K +621 +2%
Mackenzie Financial
133
Mackenzie Financial
Ontario, Canada
$6.68M -$774K -3,464 -10%
Rafferty Asset Management
134
Rafferty Asset Management
New York
$6.5M +$3.06M +13,707 +79%
Comerica Bank
135
Comerica Bank
Texas
$6.25M -$37.8K -169 -0.6%
SDIC
136
South Dakota Investment Council
South Dakota
$6.15M
MIM
137
MetLife Investment Management
New Jersey
$6.12M -$51.9K -232 -0.8%
ECM
138
ExodusPoint Capital Management
New York
$6.11M -$6.56M -29,362 -50%
SSCM
139
Summit Street Capital Management
New York
$6.08M -$1.96M -8,764 -23%
GIP
140
Granite Investment Partners
California
$6.03M +$37.6K +168 +0.6%
BC
141
Brookfield Corp
Ontario, Canada
$5.83M -$1.18M -5,293 -16%
ACP
142
Acuta Capital Partners
California
$5.76M +$3.24M +14,500 +112%
State of New Jersey Common Pension Fund D
143
State of New Jersey Common Pension Fund D
New Jersey
$5.51M
SFI
144
Susquehanna Fundamental Investments
Pennsylvania
$5.45M +$5.82M +26,021 New
SSA
145
Schonfeld Strategic Advisors
New York
$5.37M -$491K -2,195 -8%
DekaBank Deutsche Girozentrale
146
DekaBank Deutsche Girozentrale
Germany
$5.36M +$20.6K +92 +0.4%
AG
147
Algert Global
California
$5.29M +$1.35M +6,018 +31%
YCM
148
Yousif Capital Management
Michigan
$5M -$494K -2,208 -8%
Ohio Public Employees Retirement System (OPERS)
149
Ohio Public Employees Retirement System (OPERS)
Ohio
$4.99M +$359K +1,608 +7%
T. Rowe Price Associates
150
T. Rowe Price Associates
Maryland
$4.78M -$24.6M -109,938 -83%

UTHR Hedge Fund Activity: Q3 2022 in Review

461 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q3 2022, worth a combined $9.45B — down 8.5% from $10.3B a quarter earlier.

Sellers outnumbered buyers: 61 funds closed out of UTHR and 54 opened new positions — a net loss of 7 holders — while 160 trimmed existing stakes and 170 added.

The largest buyer was Janus Henderson Group, adding an estimated $211M. The largest seller was Renaissance Technologies, cutting an estimated $54.4M.

  • 461 institutional investors held United Therapeutics (UTHR) as of Q3 2022, down from 472 in Q2 2022.
  • Funds reported $9.45B of United Therapeutics stock for Q3 2022, down 8.5% quarter-over-quarter.
  • 54 funds opened new United Therapeutics positions in Q3 2022 and 61 closed out, a net change of -7 holders.
  • The largest United Therapeutics buyer in Q3 2022 was Janus Henderson Group, an estimated $211M added.
  • The largest United Therapeutics seller in Q3 2022 was Renaissance Technologies, an estimated $54.4M sold.

Based on aggregated 13F filings for Q3 2022.